Significant association of Ku80 single nucleotide polymorphisms with bladder cancer susceptibility in taiwan

Anticancer Research

Volumn 29, Issue 4, 2009, Pages 1275-1280

  Chang, Chao Hsiang ^a,b   Chiu, Chang Fang ^b,c   Liang, Shiu Yun ^b   Hsi Chin, Wu ^a,b   Chang, Chia Lin ^b   Tsai, Chia Wen ^b,d   Wang, Hwei Chung ^b   Hong Zin, Lee ^e   Da Tian, Bau ^b,c,d  

^a Department of Urology ^*  (Taiwan)

^b Terry Fox Cancer Research Laboratory   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d Graduate Institute of Chinese Medical Science   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Bladder cancer; Carcinogenesis; Ku80; Polymorphism

Indexed keywords

GUANINE; THYMINE;

ALCOHOL CONSUMPTION; ALLELE; ARTICLE; BLADDER CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA REPAIR; GENE FREQUENCY; GENE FUNCTION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC STABILITY; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; INTRON; KU80 GENE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REGULATOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TAIWAN;

ANTIGENS, NUCLEAR; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; SURVIVAL RATE; TAIWAN; URINARY BLADDER NEOPLASMS;

EID: 64949086386     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Parkin DM: International variation. Oncogene 23: 6329-6340, 2004.
2. Franekova M, Halasova E, Bukovska E, Luptak J and Dobrota D: Gene polymorphisms in bladder cancer. Urol Oncol 26: 1-8, 2008.
3. Wang YH, Lee YH, Tseng PT, Shen CH and Chiou HY: Human NAD(P)H:quinone oxidoreductase 1 (NQOl) and sulfotransferase 1A1 (SULT1A1) polymorphisms and urothelial cancer risk in Taiwan. J Cancer Res Clin Oncol 134: 203-209, 2008.
4. Cohen SM, Shirai T and Steineck G: Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J Urol Nephrol Suppl 205: 105-115, 2000.
5. Steineck G, Wiholm BE and Gerhardsson de Verdier M: Acetaminophen, some other drugs, some diseases and the risk of transitional cell carcinoma. A population-based case-control study. Acta Oncol 34: 741-748, 1995.
6. Pryor WA, Hales BJ, Premovic PI and Church DF: The radicals in cigarette tar: their nature and suggested physiological implications. Science 220: 425-427, 1983.
7. Karran P: DNA double-strand break repair in mammalian cells. Curr Opin Genet Dev 10: 144-150, 2000.
8. Goode EL, Ulrich CM and Potter JD: Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11: 1513-1530, 2002.
9. Hopfner KP, Putnam CD and Tainer JA: DNA double-strand break repair from head to tail. Curr Opin Struct Biol 12: 115- 122, 2002.
10. Smith GC and Jackson SP: The DNA-dependent protein kinase. Genes Dev 13: 916-934, 1999.
11. Cai QQ, Plet A, Imbert J, Lafage-Pochitaloff M, Cerdan C and Blanchard JM: Chromosomal location and expression of the genes coding for Ku p70 and p80 in human cell lines and normal tissues. Cytogenet Cell Genet 65: 221-227, 1994.
12. Li H, Vogel H, Holcomb VB, Gu Y and Hasty P: Deletion of Ku70, Ku80, or both causes early aging without substantially increased cancer. Mol Cell Biol 27: 8205-8214, 2007.
13. Chiu CF, Wang HC, Wang CH, Wang CL, Lin CC, Shen CY, Chiang SY and Bau DT: A new single nucleotide polymorphism in XRCC4 gene is associated with breast cancer susceptibility in Taiwanese patients. Anticancer Res 28: 267- 270, 2008.
14. Chiu CF, Wang CH, Wang CL, Lin CC, Hsu NY, Weng JR and Bau DT: A novel single nucleotide polymorphism in XRCC4 gene is associated with gastric cancer susceptibility in Taiwan. Ann Surg Oncol 15: 514-518, 2008.
15. Chiu CF, Wang CH, Wang CL, Lin CC, Hsu NY, Weng JR and Bau DT: A novel single nucleotide polymorphism in ERCC6 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral Oncol 44: 582-586, 2008.
16. Fu YP, Yu JC, Cheng TC, Lou MA, Hsu GC, Wu CY, Chen ST, Wu HS, Wu PE and Shen CY: Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility. Cancer Res 63: 2440-2446,2003.
17. Wang M, Zhang Z, Zhu H, Fu G, Wang S, Wu D, Zhou J, Wei Q and Zhang Z: A novel functional polymorphism C1797G in the MDM2 promoter is associated with risk of bladder cancer in a Chinese population. Clin Cancer Res 14: 3633-3640, 2008.
18. Xing J, Wu X, Vaporciyan AA, Spitz MR and Gu J: Prognostic significance of ataxia-telangiectasia mutated, DNA-dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86-kDa subunit expression in patients with non-small cell lung cancer. Cancer 112: 2756-2764, 2008.
19. Bau DT, Wu HC, Chiu CF, Lin CC, Hsu CM, Wang CL, Wang RF and Tsai FJ: Association of XPD polymorphisms with prostate cancer in Taiwanese patients. Anticancer Res 27: 2893- 2896,2007.
20. Chiu CF, Tsai MH, Tseng HC, Wang CL, Wang CH, Wu CN, Lin CC and Bau DT: A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral Oncol 44: 898-902, 2008.